文献速递乳腺乳腺X线

基于对比增强光谱乳腺摄影的瘤内及瘤周影像组学用于术前预测乳腺癌新辅助化疗效果

Intratumoral and peritumoral radiomics for preoperative prediction of neoadjuvant chemotherapy effect in breast cancer based on contrast-enhanced spectral mammography.
PubMed 文献 · Eur Radiol · 2022-01-23

回顾性分析118例接受术前对比增强光谱乳腺摄影和新辅助化疗的乳腺癌患者,按检查时间分为训练集81例和测试集37例,提取瘤内及瘤周影像组学特征构建5种影像组学标签,以病理评估化疗效果。瘤内+5mm瘤周区域标签在测试集获得最高AUC 0.85(95%CI 0.72-0.98),校准曲线、P-R曲线和DCA显示五种标签预测性能良好。

要点

  • 基于对比增强光谱乳腺摄影的瘤内及瘤周影像组学标签在预测乳腺癌新辅助化疗效果方面表现出良好性能。
  • 瘤内+5mm瘤周区域影像组学标签在测试集获得最高AUC 0.85(95%CI 0.72-0.98)。
  • 校准曲线、P-R曲线和DCA显示五种影像组学标签均具有良好预测性能。

核心结论

  • 基于对比增强光谱乳腺摄影的瘤内及瘤周影像组学在预测乳腺癌新辅助化疗效果方面显示出潜力,可指导治疗决策。

研究设计与样本

  • 回顾性分析2017年7月至2020年6月接受术前对比增强光谱乳腺摄影和新辅助化疗的118例乳腺癌患者,按检查时间分为训练集81例和测试集37例,以病理评估新辅助化疗效果为参考标准。

关键影像表现/征象

  • 从对比增强光谱乳腺摄影图像中提取瘤内及瘤周影像组学特征。
  • 通过Mann-Whitney U检验和LASSO回归筛选特征,共筛选出10个影像组学特征用于建立瘤内+5mm瘤周区域影像组学标签。

诊断标准与关键数值

  • 基于瘤内区域、5mm瘤周区域、10mm瘤周区域、瘤内+5mm瘤周区域、瘤内+10mm瘤周区域分别构建5种影像组学标签。
  • 瘤内+5mm瘤周区域影像组学标签在测试集获得最高AUC 0.85(95%CI 0.72-0.98)。
  • 校准曲线、P-R曲线和DCA显示5种影像组学标签预测性能良好。

临床应用与阅片要点

  • 基于对比增强光谱乳腺摄影的瘤内及瘤周影像组学标签可能有助于术前预测乳腺癌新辅助化疗效果并指导治疗决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigative the performance of intratumoral and peritumoral radiomics based on contrast-enhanced spectral mammography (CESM) to preoperatively predict the effect of the neoadjuvant chemotherapy (NAC) of breast cancers.

MATERIALS AND METHODS: A total of 118 patients with breast cancer who underwent preoperative CESM and NAC from July 2017 to June 2020 were retrospectively analyzed, and the patients were grouped into training (n = 81) and test sets (n = 37) according to the CESM examination time. NAC effect for each patient was assessed by pathology. Intratumoral and peritumoral radiomics features were extracted from CESM images, and feature selection was performed through the Mann-Whitney U test and least absolute shrinkage and selection operator regression (LASSO). Five radiomics signatures based on intratumoral regions, 5-mm peritumoral regions, 10-mm peritumoral regions, intratumoral regions + 5-mm peritumoral regions, and intratumoral regions + 10-mm peritumoral regions were calculated through a linear combination of selected features weighted by their respective coefficients. The prediction performance of radiomics signatures was assessed by the area under the receiver operator characteristic (ROC) curve, the precision-recall (P-R) curve, the calibration curve, and decision curve analysis (DCA).

RESULTS: Ten radiomics features were selected to establish the radiomics signature of intratumoral regions + 5-mm peritumoral regions, which yielded a maximum AUC of 0.85 (95% CI, 0.72-0.98) in the test set. The calibration curves, P-R curves, and DCA showed favorable predictive performance of the five radiomics signatures.

CONCLUSION: The intratumoral and peritumoral radiomics based on CESM exhibited potential for predicting the NAC effect in breast cancer, which could guide treatment decisions.

KEY POINTS: • The intratumoral and peritumoral CESM-based radiomics signatures show good performance in predicting the NAC effect in breast cancer.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Mao, Shi, Lian, et al. Intratumoral and peritumoral radiomics for preoperative prediction of neoadjuvant chemotherapy effect in breast cancer based on contrast-enhanced spectral mammography. Eur Radiol. 2022. PMID: 35066632. doi:10.1007/s00330-021-08414-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。